What are the advertising rules for registered nurses in Australia?
CompliGUARD reviews this compliance area against TGA · AHPRA · FSANZ · ACCC frameworks for Australian health brands — here's what the regulations say.
CompliGUARD reviews registered nurse advertising against AHPRA's advertising rules under the National Law. Registered nurses are registered with AHPRA under the Nursing and Midwifery Board of Australia and must comply with s.133 of the Health Practitioner Regulation National Law — including the ban on patient testimonials, unrealistic outcome claims, and inducements — with particular complexity arising where nurses operate cosmetic, aesthetics, or independent health service businesses.
The rule: Health Practitioner Regulation National Law, s.133; AHPRA Guidelines for Advertising a Regulated Health Service, December 2020; Nursing and Midwifery Board of Australia Standards
Nursing is one of 15 professions regulated by AHPRA under the Health Practitioner Regulation National Law. All registered nurse advertising — including advertising for nursing-led clinics, cosmetic nursing businesses, independent nurse practitioner services, and any other health service provided by a registered nurse — is subject to s.133 and the AHPRA Guidelines for Advertising a Regulated Health Service. The Nursing and Midwifery Board of Australia has additional practice standards relevant to scope of practice that intersect with advertising obligations — advertising services beyond a nurse's scope of practice creates both regulatory and advertising compliance risks. Registered nurses operating cosmetic injecting or aesthetics businesses face particularly complex advertising obligations given the intersection of s.133 prohibitions with TGA regulations on advertising cosmetic injectables and therapeutic devices.
What this means in practice
- Apply s.133 prohibitions to all advertising — no patient testimonials, no before-and-after images implying specific outcomes, no superiority claims, no inducements.
- Exercise particular caution in cosmetic nursing advertising — before-and-after images for cosmetic procedures are among the most commonly complained-about content types for nursing advertising.
- Do not advertise services beyond your scope of practice as a registered nurse — advertising services that require medical officer authorisation or oversight without appropriately disclosing the service model may be misleading.
- Where advertising therapeutic goods administered in the course of nursing practice (injectables, devices), apply TGA Advertising Code requirements in addition to s.133 obligations.
- Retain pre-publication compliance records — AHPRA actively monitors nursing advertising, particularly in the cosmetic and aesthetics sector.
Common mistakes
Publishing before-and-after cosmetic procedure images
Before-and-after images for cosmetic injectable procedures — lip filler, anti-wrinkle injections, skin treatments — create an unrealistic expectation of benefit under s.133(1)(c). This is the single most common advertising breach for cosmetic nursing businesses in Australia. AHPRA and the Nursing and Midwifery Board have specifically addressed cosmetic procedure advertising in guidance materials.
Remove all before-and-after cosmetic procedure imagery from advertising. Use educational imagery about procedures and their general nature without implying specific outcomes for individual patients.
Using patient outcome testimonials for cosmetic procedures
Patient testimonials about cosmetic treatment outcomes — 'I love my results', 'best lip filler I've ever had' — are prohibited testimonials under s.133(1)(c). The prohibition applies with equal force to cosmetic service testimonials as to clinical health service testimonials.
Do not publish, repost, or draw attention to patient testimonials about cosmetic procedures. Replace with educational content about the procedure, what the consultation process involves, and relevant safety information.
Advertising cosmetic injectables without appropriate TGA compliance
Cosmetic injectables (anti-wrinkle injections containing botulinum toxin, dermal fillers) are therapeutic goods regulated by the TGA. Advertising these products or their effects in consumer-directed advertising engages TGA Advertising Code obligations in addition to s.133 — including restrictions on advertising prescription medicines to consumers.
Apply TGA advertising rules to any content that promotes specific injectable products or their effects. Anti-wrinkle injection advertising directed at consumers faces specific TGA restrictions — seek regulatory advice on the specific requirements for your advertising model.
Compliant vs non-compliant example
❌ NON-COMPLIANT
Publishing before-and-after cosmetic procedure images
✅ COMPLIANT
Remove all before-and-after cosmetic procedure imagery from advertising. Use educational imagery about procedures and their general nature without implying specific outcomes for individual patients.
The enforcement context
The Nursing and Midwifery Board of Australia actively monitors cosmetic nursing advertising and has published specific guidance on advertising standards for nurses providing cosmetic services. AHPRA's automated monitoring tools scan nursing business websites and social media — cosmetic nursing advertising is a specific focus area. Penalties for s.133 breaches reach $60,000 per offence for individuals. TGA enforcement applies separately to therapeutic good advertising.
Before you publish, check it.
CompliGUARD reviews registered nurse advertising against AHPRA Guidelines s.133 and TGA requirements for therapeutic goods — with specific analysis for cosmetic nursing and aesthetics advertising.
Start free reviewRelated questions
Regulatory references
- Health Practitioner Regulation National Law, s.133
- AHPRA Guidelines for Advertising a Regulated Health Service, December 2020
- Nursing and Midwifery Board of Australia — Professional Standards
- Nursing and Midwifery Board of Australia — Cosmetic Procedures Guidance
- Therapeutic Goods Advertising Code 2021 (Cth)
- TGA — Advertising of Prescription Medicines to Consumers